Dr Nabil Azar, MD | |
1340 Broad Ave, Suite 310, Gulfport, MS 39501-2418 | |
(228) 575-1400 | |
(228) 575-1414 |
Full Name | Dr Nabil Azar |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 41 Years |
Location | 1340 Broad Ave, Gulfport, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033159140 | NPI | - | NPPES |
00115228 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 14521 (Mississippi) | Secondary |
208M00000X | Hospitalist | 14521 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Deaconess Homecare- Region 1 | Laurel, MS | Home health agency |
Memorial Hospital At Gulfport | Gulfport, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Memorial Hospital At Gulfport | 2466524012 | 376 |
Exceed Physical Therapy Llc | 8123378338 | 82 |
News Archive
The structure of the human brain is complex, reminiscent of a circuit diagram with countless connections. But what role does this architecture play in the functioning of the brain?
According to a report by charity Age UK, spending on social care for the elderly has been cut by around £600m this year. The research was based on 139 council responses under the Freedom of Information Act, and has uncovered an 8.4% cut to elderly care budgets.
Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the first quarter of fiscal year 2011, which reflects the three month period ended June 30, 2010.
Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.
› Verified 6 days ago
Entity Name | Memorial Hospital At Gulfport |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215546635 PECOS PAC ID: 2466524012 Enrollment ID: O20090515000396 |
News Archive
The structure of the human brain is complex, reminiscent of a circuit diagram with countless connections. But what role does this architecture play in the functioning of the brain?
According to a report by charity Age UK, spending on social care for the elderly has been cut by around £600m this year. The research was based on 139 council responses under the Freedom of Information Act, and has uncovered an 8.4% cut to elderly care budgets.
Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the first quarter of fiscal year 2011, which reflects the three month period ended June 30, 2010.
Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Nabil Azar, MD Po Box 1810, Gulfport, MS 39502-1810 Ph: (228) 575-1400 | Dr Nabil Azar, MD 1340 Broad Ave, Suite 310, Gulfport, MS 39501-2418 Ph: (228) 575-1400 |
News Archive
The structure of the human brain is complex, reminiscent of a circuit diagram with countless connections. But what role does this architecture play in the functioning of the brain?
According to a report by charity Age UK, spending on social care for the elderly has been cut by around £600m this year. The research was based on 139 council responses under the Freedom of Information Act, and has uncovered an 8.4% cut to elderly care budgets.
Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the first quarter of fiscal year 2011, which reflects the three month period ended June 30, 2010.
Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.
› Verified 6 days ago
Ekow E Acquah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 15200 Community Rd, Gulfport, MS 39503 Phone: 228-575-7112 Fax: 228-575-7190 | |
Ann Hughley, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-864-8454 Fax: 228-864-8454 | |
Dr. Charles A Stanich, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4500 13th Street, Gulfport, MS 39501 Phone: 228-867-4396 Fax: 228-867-5354 | |
Patrick Stovall, D.O. Hospitalist Medicare: Medicare Enrolled Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-4396 Fax: 228-867-5354 | |
Phillip D Compton Ii, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 15286 Community Rd, Gulfport, MS 39503 Phone: 228-832-5151 Fax: 228-832-6320 | |
Dr. Jonathan A Mihnovets, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4500 13th Street, Gulfport, MS 39501 Phone: 228-867-4396 Fax: 228-867-5354 | |
Melantha Dorthea Manns, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4500 13th Street, Gulfport, MS 39501 Phone: 228-867-4396 Fax: 228-867-5354 |